An aide to US Senate Majority Leader Chuck Schumer said on Tuesday that Schumer expects to lead a bipartisan congressional delegation to China, Japan, and South Korea soon.
In Washington, D.C., the United States Capitol is viewed.
Republican Mike Crapo is the trip’s main Republican, according to his office
In a recently published article from Stars and Stripes, the China visit would be a high-profile trip by Schumer, a Democrat who has repeatedly urged the United States to take a harder line on China and would follow visits by a series of Biden administration officials including Commerce Secretary Gina Raimondo in August. Two congressional delegations are planned travels to China this autumn, the latest in a series of high-level visits supported by the Biden administration as Washington debates how to repair a dangerously strained relationship with Beijing.
The Chinese Embassy in Washington did not immediately respond to a request for comment on the scheduled trip. The Biden administration has pushed to improve relations with China, notably on economic and security issues, amid worries that tensions between the two heavyweights might escalate.
READ ALSO: A Stolen Van Gogh Painting Was Returned In An IKEA Bag
Schumer announced a fresh push to fight Chinese competitiveness in May
In a recently published article from The Washington Post, following the passage of a broad bill last year to boost competition with Beijing in semiconductors and other technology, Schumer and Democratic committee leaders announced in May that they would write legislation to limit the flow of technology to China, deter China from starting a conflict with Taiwan, and tighten rules to prevent US capital from flowing to Chinese companies.
One of the few really bipartisan feelings in the continuously divided United States is a desire for a tough stance on China. Last year’s measure was overwhelmingly supported by both Democrats and Republicans in Congress. This year’s measure would also seek financing for greater domestic investments in important technological fields, as well as give a stronger US alternative to China’s Belt and Road global infrastructure program, an effort to challenge Beijing’s worldwide dominance.
READ ALSO: Common Cold Medication — Efficacy Rejected By FDA Advisers
